Montelukast reduces asthma exacerbations in 2- to 5-year-old children with intermittent asthma

American Journal of Respiratory and Critical Care Medicine

Volumn 171, Issue 4, 2005, Pages 315-322

  Bisgaard, Hans ^a   Zielen, Stefen ^b   Garcia Garcia, María Luz ^b   Johnston, Sebastian L ^b   Gilles, Leen ^b   Menten, Joris ^b   Tozzi, Carol A ^b   Polos, Peter ^b  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b NONE

Author keywords

Controlled clinical trial; Leukotriene receptor antagonist; Pediatric

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MONTELUKAST; PLACEBO;

ARTICLE; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG UTILIZATION; FEMALE; FOLLOW UP; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOMES RESEARCH; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; SCORING SYSTEM; SENSITIVITY ANALYSIS; SIDE EFFECT; SYMPTOM; VIRUS IDENTIFICATION;

ACETATES; ADRENAL CORTEX HORMONES; ADRENERGIC BETA-AGONISTS; ANTI-ASTHMATIC AGENTS; ASTHMA; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; EOSINOPHILS; FEMALE; HUMANS; MALE; QUINOLINES; RESPIRATORY TRACT INFECTIONS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 13544276896     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.200407-894OC     Document Type: Article

References (25)

1. Wright AL, Taussig LM. Lessons from long-term cohort studies: childhood asthma. Eur Respir J Suppl 1998;27:17s-22s.
2. Martinez FD, Stern DA, Wright AL, Taussig LM, Halonen M. Differential immune response to acute lower respiratory illness in early life and subsequent development of persistent wheezing and asthma. J Allergy Clin Immunol 1998;102:915-920.
3. Sears MR. Evolution of asthma through childhood. Clin Exp Allergy 1998;28:82-89.
4. Global Initiative for Asthma. Global strategy for asthma management and prevention. NHBLI/WHO workshop report. Based on March 1993 meeting. Bethesda, MD: National Heart, Lung, and Blood Institute; 1995. NIH Publication No. 95-3659.
5. Global Initiative for Asthma. Pocket Guide for Asthma Management and Prevention. Bethesda, MD: National Institutes of Health; 1998. NIH Publication No. 96-3659B.
6. Doull IJ, Lampe FC, Smith S, Schreiber J, Freezer NJ, Holgate ST. Effect of inhaled corticosteroids on episodes of wheezing associated with viral infection in school age children: randomized double blind placebo controlled trial. BMJ 1997;315:858-862.
7. Wilson N, Sloper K, Silverman M. Effect of continuous treatment with topical corticosteroid on episodic viral wheeze in preschool children. Arch Dis Child 1995;72:317-320.
8. McKean M, Ducharme F. Inhaled steroids for episodic viral wheeze of childhood (Cochrane Review). The Cochrane Library, Issue 4, 2002. Oxford. Update Software Ltd. Available from: http://www.update-software.com/cochrane/. Accessed October 2004.
9. Johnston SL, Pattemore PK, Sanderson G, Smith S, Lampe F, Josephs L, Symington P, O'Toole S, Myint SH, Tyrrell DAJ, et al. Community study of the role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ 1995;310:1225-1229.
10. Nicholson KG, Kent J, Ireland DC. Respiratory viruses and exacerbations of asthma in adults. BMJ 1993;307:982-986.
11. van Schaik SM, Tristram DA, Nagpal IS, Hintz KM, Welliver RC II, Welliver RC. Increased production of IFN-gamma and cysteinyl leukotrienes in virus-induced wheezing. J Allergy Clin Immunol 1999;103:630-636.
12. Volovitz B, Welliver RC, De Castro G, Krystofik DA, Ogra PL. The release of leukotrienes in the respiratory tract during infection with respiratory syncytial virus: role in obstructive airway disease. Pediatr Res 1988;24:504-507.
13. Reiss TF, Chervinsky P, Dockhorn RJ, Shingo S, Seidenberg B, Edwards TB, for the Montelukast Clinical Research Study Group. Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma. Arch Intern Med 1998;158:1213-1220.
14. Knorr B, Matz J, Bernstein JA, Nguyen H, Seidenberg BC, Reiss TF, Becker A, for the Pediatric Montelukast Study Group. Montelukast for chronic asthma in 6- to 14-year-old children. JAMA 1998;279:1181-1186.
15. Knorr B, Franchi LM, Bisgaard H, Vermeulen JH, LeSouef P, Santanello N, Michele TM, Reiss TF, Nguyen HH, Bratton DL. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years. Pediatrics 2001;108:E48.
16. Dahlen S-E, Malmstrom K, Nizankowska E, Dahlen B, Kuna P, Kowalski M, Lumry WR, Picado C, Stevenson DD, Bousquet J, et al. Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist. Am J Respir Crit Care Med 2002;165:9-14.
17. Bisgaard H for the Study Group on Montelukast and Respiratory Syncytial Virus. A randomized trial of montelukast in respiratory syncytial virus postbronchiolitis. Am J Respir Crit Care Med 2003;167:379-383.
18. Bisgaard H, Zielen S, Garcia-Garcia ML, Johnston SL, Gilles L, Menten J, Tozzi CA, Polos P. Montelukast reduces rescue medication use in viral-induced asthma exacerbations (The PREVIA Study). Am J Respir Crit Care Med 2004;169:A149.
19. Bisgaard H, Garcia-Garcia ML, Johnston SL, Gilles L, Meuten J, Tozzi CA, Polos P. Montelukast reduces viral-induced asthma exacerbations: The PREVIA Study. Eur Respir J 2004;24:212s.
20. Johnston SL, Pattemore PK, Sanderson G, Smith S, Campbell MJ, Josephs LK, Cunningham A, Robinson BS, Myint SH, Ward ME, et al. The relationship between upper respiratory infections and hospital admissions for asthma: a time-trend analysis. Am J Respir Crit Care Med 1996;154:654-660.
21. Williams JV, Harris PA, Tollefson SJ, Halburnt-Rush LL, Pingsterhaus JM, Edwards KM, Wright PF, Crowe JE Jr. Human metapneumonia and lower respiratory tract disease in otherwise healthy infants and children. N Engl J Med 2004;350:443-450.
22. Calhoun WJ, Sutton LB, Emmett A, Dorinsky PM. Asthma variability in patients previously treated with beta2-agonists alone. J Allergy Clin Immunol 2003;112:1088-1094.
23. Colice GL, Burgt JV, Song J, Stampone P, Thompson PJ. Categorizing asthma severity. Am J Respir Crit Care Med 1999;160:1962-1967.
24. Vignola AM, Chanez P, Campbell AM, Souques F, Lebel B, Enander I, Bousquet J. Airway inflammation in mild intermittent and persistent asthma. Am J Respir Crit Care Med 1998;157:403-409.
25. Barbato A, Turato G, Baraldo S, Bazzan E, Calabrese F, Tura M, Zuin R, Beghe B, Maestrelli P, Fabbri LM, et al. Airway inflammation in childhood asthma. Am J Respir Crit Care Med 2003;168:798-803.